A technology that enables high throughput, scalability, and novel applications
Investigations needing strain resolution may be opened due to an action level exceedance, a media fill or sterility test failure, or identification of an adverse trend in the EM tracking and trending data.
While we maintain an extensive list of species with validated SLST/MLST schemes, if a validated strain typing scheme is not available, a new method may be developed using Sanger sequencing technology.
If that development is not possible, the Accugenix Next Generation Sequencing (Accugenix NGS) strain comparison method can be used.
Schedule a walkthrough of our Accugenix NGS services today to reduce downtime and uncertainty.